News & Updates

Pembrolizumab extends RFS in stage II melanoma

01 Nov 2021 by

Pembrolizumab extended recurrence-free survival (RFS) in patients with high-risk stage II melanoma who had undergone complete resection, interim analysis results of the phase III KEYNOTE-716 trial showed.

Pembrolizumab extends RFS in stage II melanoma

01 Nov 2021

Cancer patients bear brunt of COVID-19 pandemic

01 Nov 2021

The COVID-19 pandemic has evidently affected the care and well-being of cancer patients, particularly those with advanced stages, reveals a recent study.

Cancer patients bear brunt of COVID-19 pandemic

01 Nov 2021

Dacomitinib monotherapy approved as first-line treatment for metastatic NSCLC

01 Nov 2021 by

The National Pharmaceutical Regulatory Agency (NPRA) has approved dacomitinib (VIZIMPRO®, Pfizer) as a monotherapy for the first-line treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR)-activating mutations.

Dacomitinib monotherapy approved as first-line treatment for metastatic NSCLC

01 Nov 2021

Poor metabolic health may lead to subsequent gastrointestinal cancers

31 Oct 2021

Individuals with long-term metabolic syndrome are at increased risk of developing gastrointestinal cancer overall, including colorectal and pancreatic cancers and hepatocellular carcinoma, with the risk increase independent of genetic predisposition, a study has found.

Poor metabolic health may lead to subsequent gastrointestinal cancers

31 Oct 2021

Local failure common in metastases from right-sided primary CRC treated with SABR

31 Oct 2021

Local failure (LF) is more likely to occur in colorectal cancer (CRC) metastases treated with stereotactic ablative radiotherapy (SABR) if originating from right-sided primary CRC compared with left-sided, a study has found. In addition, LF rates are highest with liver metastases than other metastatic sites.

Local failure common in metastases from right-sided primary CRC treated with SABR

31 Oct 2021

Patients presenting with advanced-stage pancreatic cancer reveal cracks in imaging-based surveillance

31 Oct 2021

High-risk individuals who develop neoplastic progression to pancreatic cancer or high-grade dysplasia can present at an advanced stage despite showing no lesions during prior imaging surveillance evaluations, a new study has found.

Patients presenting with advanced-stage pancreatic cancer reveal cracks in imaging-based surveillance

31 Oct 2021

5-alpha reductase inhibitor exposure does not mar prostate cancer detection with MRI

30 Oct 2021

Long-term exposure to 5-alpha reductase inhibitors (5-ARIs) is not associated with impaired detection of significant cancer on magnetic resonance imaging (MRI) but appears to influence the ability of apparent diffusion coefficient (ADC) metrics to discriminate between lesions harbouring significant and benign cancers, reveals a study.

5-alpha reductase inhibitor exposure does not mar prostate cancer detection with MRI

30 Oct 2021

Intraoperative dexamethasone may confer survival benefit in non-immunogenic cancers

30 Oct 2021 by

The intraoperative administration of dexamethasone in patients with non-immunogenic cancers may have survival benefits, according to a retrospective cohort study from the US presented at Anesthesiology 2021.

Intraoperative dexamethasone may confer survival benefit in non-immunogenic cancers

30 Oct 2021

Antidepressant useful in pain management following abdominal cancer surgery

29 Oct 2021

Administering a single dose of the serotonin and norepinephrine reuptake inhibitor (SNRI) duloxetine prior to a major abdominal cancer surgery leads to lower postoperative pain, reduced opioid requirement, and better quality of recovery, according to a study.

Antidepressant useful in pain management following abdominal cancer surgery

29 Oct 2021

L-arginine supplementation helps prevent infection after radical cystectomy

29 Oct 2021

Postoperative infection is one of the most common complications of radical cystectomy, but preoperative immunonutrition with an L-arginine-based supplement appears to significantly reduce such risk, according to a study.

L-arginine supplementation helps prevent infection after radical cystectomy

29 Oct 2021

News & Updates

Filter by Specialty:

Specialty:

Pembrolizumab extends RFS in stage II melanoma

Pembrolizumab extends RFS in stage II melanoma

Cancer patients bear brunt of COVID-19 pandemic

Cancer patients bear brunt of COVID-19 pandemic

Dacomitinib monotherapy approved as first-line treatment for metastatic NSCLC

Dacomitinib monotherapy approved as first-line treatment for metastatic NSCLC

Poor metabolic health may lead to subsequent gastrointestinal cancers

Poor metabolic health may lead to subsequent gastrointestinal cancers

Local failure common in metastases from right-sided primary CRC treated with SABR

Local failure common in metastases from right-sided primary CRC treated with SABR

Patients presenting with advanced-stage pancreatic cancer reveal cracks in imaging-based surveillance

Patients presenting with advanced-stage pancreatic cancer reveal cracks in imaging-based surveillance

5-alpha reductase inhibitor exposure does not mar prostate cancer detection with MRI

5-alpha reductase inhibitor exposure does not mar prostate cancer detection with MRI

Intraoperative dexamethasone may confer survival benefit in non-immunogenic cancers

Intraoperative dexamethasone may confer survival benefit in non-immunogenic cancers

Antidepressant useful in pain management following abdominal cancer surgery

Antidepressant useful in pain management following abdominal cancer surgery

L-arginine supplementation helps prevent infection after radical cystectomy

L-arginine supplementation helps prevent infection after radical cystectomy